Position in FTRE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,502,470
+$52,662 QoQ
Shares Held
316,234
-45.3% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 334 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Derivatives in FTRE
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$1,235,000
PutShares
250,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. FTRE ranks #141 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in FTRE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,502,470 | 316,234 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,449,808 | 578,536 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,727,448 | 274,055 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $6,908,971 | 820,543 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,235,000 | 250,000 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $5,871,485 | 1,188,560 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,033,113 | 401,737 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,380,661 | 395,746 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,978,640 | 98,932 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,987,752 | 128,010 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,572,683 | 163,744 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,866,107 | 139,430 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $107,448,337 | 3,758,249 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,346 | 69 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||